References
- GibsonGJLoddenkemperRSibilleYLundbäckBFletcherMEuropean Respiratory Society. European Lung White Book2013 Available from: www.erswhitebook.orgAccessed March 12, 2015
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for Diagnosis, Management and Prevention of COPD2014 Available from: www.goldcopd.comAccessed January 12, 2015
- RobertsSDFarberMDKnoxKSFEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of ageChest2006130120020616840402
- CarolanBJSutherlandERClinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advancesJ Allergy Clin Immunol2013131362763423360757
- BujarskiSParulekarADSharafkhanehAHananiaNAThe asthma COPD overlap syndrome (ACOS)Curr Allergy Asthma Rep201515350925712010
- DecramerMSelroosOAsthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseasesInt J Clin Pract200559438539815853852
- PostmaDSReddelHKten HackenNHvan den BergeMAsthma and chronic obstructive pulmonary disease: similarities and differencesClin Chest Med201435114315624507842
- TashkinDPCelliBDecramerMBronchodilator responsiveness in patients with COPDEur Respir J200831474275018256071
- CalverleyPMAlbertPWalkerPPBronchodilator reversibility in chronic obstructive pulmonary disease: use and limitationsLancet Respir Med20131756457324461617
- O’ReillyJJonesMMParnhamJLovibondKRudolfMManagement of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidanceBMJ2010340c313420581031
- LouieSZekiAASchivoMChanALYonedaKYAvdalovicMThe asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerationsExpert Rev Clin Pharmacol20136219721923473596
- MelaniASBonaviaMCilentiVInhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med2011105693093821367593
- LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthmaRespir Med2008102459360418083019
- ChrystynHPriceDNot all asthma inhalers are the same: factors to consider when prescribing an inhalerPrim Care Respir J200918424324919513494
- DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
- BrocklebankDRamFWrightJComparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literatureHealth Technol Assess2001526114911701099
- SchulteMOsseiranKBetzRHandling of and preferences for available dry powder inhaler systems by patients with asthma and COPDJ Aerosol Med Pulm Drug Deliv200821432132818823257
- ChrystynHCloser to an “ideal inhaler” with the Easyhaler®. An innovative dry powder inhalerClin Drug Invest2006264175183
- ChrystynHHaahtelaTReal-life inhalation therapy–inhaler performance and patient education matterEur Respir Dis201281118
- American Thoracic SocietyStandardization of spirometry. 1994 updateAm J Respir Crit Care Med19951523110711367663792
- KauppiPKupiainenHLindqvistAOverlap syndrome of asthma and COPD predicts low quality of lifeJ Asthma201148327928521323613
- AndersenHLampelaPNevanlinnaASaynajakangasOKeistinenTHigh hospital burden in overlap syndrome of asthma and COPDClin Respir J2013734234623362945
- SuzukiTTadaYKawataNClinical, physiological and radiological features of asthma-chronic obstructive pulmonary disease syndromeInt J Chron Obstruct Pulmon Dis20151094795426028967
- LavoriniFFontanaGAUsmaniOSNew inhaler devices – the good, the bad and the uglyRespiration201488131524902629
- PerngW-GHuangH-YChenH-MLeeY-CPerngR-PCharacteristics of airway inflammation and bronchodilator reversibility in COPD. A potential guide to treatmentChest2004126237538115302720
- HaahtelaTVidgrenMNybergAKorhonenPLaurikainenKSilvastiMA novel multiple dose powder inhaler. Salbutamol powder and aerosol give equal bronchodilatation with equal dosesAnn Allergy19947221781828109809
- SilvastiMLaurikainenKNieminenMSingle dose comparison between a novel multiple dose powder inhaler and a conventional metered dose inhaler in asthmatic patientsActa Ther Res199319125135
- NieminenMVidgrenMLaurikainenKEasyhaler®, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to useRespiration199461137418177971
- TammivaaraRAaltoELehtonenKComparison of a novel salbutamol multidose powder inhaler with a salbutamol metered dose inhaler in patients with asthmaCurr Ther Res19975810734744
- GuyattGHTownsendMNogradiSPugsleySOKellerJLNewhouseMTAcute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitationAnn Intern Med1988148919491952
- BrandPLQuanjerPHPostmaDSInterpretation of bronchodilator response in patients with obstructive airways diseaseThorax19924764294361496502
- TanWCVollmerWMLamprechtBWorldwide pattern of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease studyThorax201267871872622544896
- PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
- AlbertPAgustiAEdwardsLBronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary diseaseThorax201267870170822696176
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- IPPB Trial GroupIntermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. A clinical trialAnn Intern Med1985995612620
- CelliBRMacNeeWStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
- JanssensJPPacheJCNicodLPPhysiological changes in respiratory function associated with ageingEur Respir J19991319720510836348
- PalanderAMattilaTKarhuMMuttonenEIn vitro comparison of three salbutamol-containing multidose dry powder inhalers. Buventol Easyhaler®, Inspiryl Turbuhaler®, and Ventoline DiskusClin Drug Invest20002012533
- VidgrenMSilvastiMKorhonenPKinkelinAFrischerBSternKClinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamolArzneim.-Forsch/Drug Res19954544477893268
- NewmanSPPitcairnGRAdkinDAVidgrenMTSilvastiMComparison of beclomethasone dipropionate delivery by Easyhaler® dry powder inhaler and pMDI plus large volume spacerJ Aerosol Med200114221722511681653
- GálffyGMezeiGNémethGInhaler competence and patient satisfaction with Easyhaler: results of two real-life multicentre studies in asthma and COPDDrugs RD2013133215222
- GinerJTorrejónMRamosAPatient preference in the choice of dry powder inhalersArch Bronconeumol200440310610914998473
- BroedersMEACVinckenWCorbettaLOn behalf of the ADMIT Working GroupThe ADMIT series – Issues in Inhalation Therapy. 7. Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation techniquePrim Care Respir J201120333834321808941
- VinckenWDekhuijzenRBarnesPOn behalf of the ADMIT groupThe ADMIT series – Issues in Inhalation Therapy. 4. How to choose inhaler devices for the treatment of COPDPrim Care Respir J2010193102019890594
- LavoriniFFontanaGAInhaler technique and patient’s preference for dry powder inhaler devicesExpert Opin Drug Deliv20141111324093806
- MüllerVGálffyGEszesNAsthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized dose metered dose inhaler extrafine formulationBMC Pulm Med20111114021762500